The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| KRMD | +41.64% | +4.42% | +0.87% | +11,125% |
| S&P | +13.19% | +87.83% | +13.42% | +1,949% |
KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Mahwah, NJ.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $10.40M | 27.2% |
| Gross Profit | $6.06M | 22.2% |
| Gross Margin | 58.26% | -2.4% |
| Market Cap | $177.08M | 41.5% |
| Market Cap / Employee | $2.21M | 0.0% |
| Employees | 80 | -2.4% |
| Net Income | -$0.78M | 50.8% |
| EBITDA | -$0.66M | 55.1% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $8.46M | -3.9% |
| Accounts Receivable | $5.52M | 6.8% |
| Inventory | 4.4 | 12.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.80M | -15.8% |
| Short Term Debt | $0.87M | -4.8% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -13.62% | 24.5% |
| Return On Invested Capital | -25.57% | -7.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $0.01M | 100.6% |
| Operating Free Cash Flow | $0.07M | 107.1% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 9.95 | 6.94 | 10.11 | 10.72 | 51.85% |
| Price to Sales | 5.25 | 3.33 | 4.49 | 4.53 | 15.85% |
| Price to Tangible Book Value | 10.39 | 7.26 | 10.57 | 11.19 | 51.88% |
| Enterprise Value to EBITDA | -124.20 | -108.78 | -1558.60 | -259.81 | 217.84% |
| Return on Equity | -32.6% | -29.9% | -25.6% | -21.7% | -59.05% |
| Total Debt | $3.99M | $3.73M | $3.47M | $3.67M | -13.46% |
No podcast episodes available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
